best glp 1 for cholesterol Anti-atherosclerotic effects of the glucagon-like peptide-1 (GLP-1) based therapies in patients with type 2 Diabetes Mellitus: A meta-analysis A Comprehensive Review of the

Everything you need to know about what kidney stones are, what causes them to develop, and why some people are more likely to get them

Introduction Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are key therapies for type 2 diabetes and obesity, regulating blood glucose by mimicking endogenous GLP-1

A large study of over 185,000 adults with type 2 diabetes found that GLP-1 receptor agonist use was linked to a slight increase in new diabetic retinopathy cases but fewer severe eye complications, including a reduced risk of blindness

Postprandial reduction in hunger was greater after RYGB than OAGB from baseline to 12 months

Missing a single semaglutide injection won't derail your weight loss progress, but timing matters for appetite control and metabolic stability